Recent developments in the perioperative management of the paediatric cardiac patient

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Critical Care Medicine

Background:

• Improved survival rates for infants with congenital heart disease (CHD) lead to a growing adult population with complex cardiac conditions.
• Adults with CHD face increased risks of long-term complications, particularly from the perioperative period following open-heart surgery.

Purpose of the Study:

• To review recent advancements in strategies for preventing, detecting, treating, and predicting early and late complications of open-heart surgery in patients with CHD.

Main Methods:

• Review of current literature on perioperative management strategies for congenital heart surgery.
• Analysis of pharmacological interventions for bleeding and inflammation.
• Evaluation of techniques for cardiac and cerebral protection during cardiopulmonary bypass.

Main Results:

• Pharmacological agents like aprotinine and recombinant factor VIIa can mitigate perioperative bleeding.
• Steroids, complement component C4A, heparin-coated circuits, and ultrafiltration aid in managing the inflammatory response.
• Milrinone and extracorporeal life support are effective for postoperative cardiac dysfunction, while optimized cardioplegia and cerebral protection strategies are under investigation.

Conclusions:

• While surgical repair of congenital heart defects is advancing, safeguarding the heart and brain requires sustained research and clinical attention.
• Further rigorous investigation is needed to ensure optimal long-term outcomes for patients undergoing complex cardiac procedures.